Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Obesity Therapeutic Drugs market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Obesity Therapeutic Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Obesity Therapeutic Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Arena Pharmaceuticals
Takeda Pharmaceutical
Orexigen Therapeutics
Sanofi
GlaxoSmithKline
Eisai
Vivus
Shionogi
Norgine
Novo Nordisk
Roche
By Type:
Type 1
Type 2
Type 3
By End-User:
End-Users 1
End-Users 2
End-Users 3
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Obesity Therapeutic Drugs Market
-
1.3 Market Segment by Type
1.3.1 Japan Obesity Therapeutic Drugs Market Size and Growth Rate of Type 1 from 2014 to 2026
1.3.2 Japan Obesity Therapeutic Drugs Market Size and Growth Rate of Type 2 from 2014 to 2026
1.3.3 Japan Obesity Therapeutic Drugs Market Size and Growth Rate of Type 3 from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Obesity Therapeutic Drugs Market Size and Growth Rate of Application 1 from 2014 to 2026
1.4.2 Japan Obesity Therapeutic Drugs Market Size and Growth Rate of Application 2 from 2014 to 2026
1.4.3 Japan Obesity Therapeutic Drugs Market Size and Growth Rate of Application 3 from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Obesity Therapeutic Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Obesity Therapeutic Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Obesity Therapeutic Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Obesity Therapeutic Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Obesity Therapeutic Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Obesity Therapeutic Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Obesity Therapeutic Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Obesity Therapeutic Drugs Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Obesity Therapeutic Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Obesity Therapeutic Drugs by Major Types
3.4.1 Market Size and Growth Rate of Type 1
3.4.2 Market Size and Growth Rate of Type 2
3.4.3 Market Size and Growth Rate of Type 3
4 Segmentation of Obesity Therapeutic Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Obesity Therapeutic Drugs by Major End-Users
4.4.1 Market Size and Growth Rate of Obesity Therapeutic Drugs in Application 1
4.4.2 Market Size and Growth Rate of Obesity Therapeutic Drugs in Application 2
4.4.3 Market Size and Growth Rate of Obesity Therapeutic Drugs in Application 3
5 Market Analysis by Regions
-
5.1 Japan Obesity Therapeutic Drugs Production Analysis by Regions
-
5.2 Japan Obesity Therapeutic Drugs Consumption Analysis by Regions
6 Hokkaido Obesity Therapeutic Drugs Landscape Analysis
-
6.1 Hokkaido Obesity Therapeutic Drugs Landscape Analysis by Major Types
-
6.2 Hokkaido Obesity Therapeutic Drugs Landscape Analysis by Major End-Users
7 Tohoku Obesity Therapeutic Drugs Landscape Analysis
-
7.1 Tohoku Obesity Therapeutic Drugs Landscape Analysis by Major Types
-
7.2 Tohoku Obesity Therapeutic Drugs Landscape Analysis by Major End-Users
8 Kanto Obesity Therapeutic Drugs Landscape Analysis
-
8.1 Kanto Obesity Therapeutic Drugs Landscape Analysis by Major Types
-
8.2 Kanto Obesity Therapeutic Drugs Landscape Analysis by Major End-Users
9 Chubu Obesity Therapeutic Drugs Landscape Analysis
-
9.1 Chubu Obesity Therapeutic Drugs Landscape Analysis by Major Types
-
9.2 Chubu Obesity Therapeutic Drugs Landscape Analysis by Major End-Users
10 Kinki Obesity Therapeutic Drugs Landscape Analysis
-
10.1 Kinki Obesity Therapeutic Drugs Landscape Analysis by Major Types
-
10.2 Kinki Obesity Therapeutic Drugs Landscape Analysis by Major End-Users
11 Chugoku Obesity Therapeutic Drugs Landscape Analysis
-
11.1 Chugoku Obesity Therapeutic Drugs Landscape Analysis by Major Types
-
11.2 Chugoku Obesity Therapeutic Drugs Landscape Analysis by Major End-Users
12 Shikoku Obesity Therapeutic Drugs Landscape Analysis
-
12.1 Shikoku Obesity Therapeutic Drugs Landscape Analysis by Major Types
-
12.2 Shikoku Obesity Therapeutic Drugs Landscape Analysis by Major End-Users
13 Kyushu Obesity Therapeutic Drugs Landscape Analysis
-
13.1 Kyushu Obesity Therapeutic Drugs Landscape Analysis by Major Types
-
13.2 Kyushu Obesity Therapeutic Drugs Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Arena Pharmaceuticals
14.1.1 Arena Pharmaceuticals Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Takeda Pharmaceutical
14.2.1 Takeda Pharmaceutical Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Orexigen Therapeutics
14.3.1 Orexigen Therapeutics Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Sanofi
14.4.1 Sanofi Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 GlaxoSmithKline
14.5.1 GlaxoSmithKline Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Eisai
14.6.1 Eisai Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Vivus
14.7.1 Vivus Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Shionogi
14.8.1 Shionogi Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Norgine
14.9.1 Norgine Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 Novo Nordisk
14.10.1 Novo Nordisk Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
14.11 Roche
14.11.1 Roche Company Profile and Recent Development
14.11.2 Market Performance
14.11.3 Product and Service Introduction
The List of Tables and Figures (Totals 99 Figures and 128 Tables)
Figure Japan Obesity Therapeutic Drugs Market Size and Growth Rate of Type 1 from 2014 to 2026
Figure Japan Obesity Therapeutic Drugs Market Size and Growth Rate of Type 2 from 2014 to 2026
Figure Japan Obesity Therapeutic Drugs Market Size and Growth Rate of Type 3 from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Obesity Therapeutic Drugs Market Size and Growth Rate of Application 1 from 2014 to 2026
Figure Japan Obesity Therapeutic Drugs Market Size and Growth Rate of Application 2 from 2014 to 2026
Figure Japan Obesity Therapeutic Drugs Market Size and Growth Rate of Application 3 from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Obesity Therapeutic Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Obesity Therapeutic Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Obesity Therapeutic Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Obesity Therapeutic Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Obesity Therapeutic Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Obesity Therapeutic Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Obesity Therapeutic Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Obesity Therapeutic Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Obesity Therapeutic Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Obesity Therapeutic Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Obesity Therapeutic Drugs by Different Types from 2014 to 2026
-
Table Consumption Share of Obesity Therapeutic Drugs by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Type 1
Figure Market Size and Growth Rate of Type 2
Figure Market Size and Growth Rate of Type 3
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Obesity Therapeutic Drugs by Different End-Users from 2014 to 2026
-
Table Consumption Share of Obesity Therapeutic Drugs by Different End-Users from 2014 to 2026
Figure Japan Obesity Therapeutic Drugs Market Size and Growth Rate of Application 1 from 2014 to 2026
Figure Japan Obesity Therapeutic Drugs Market Size and Growth Rate of Application 2 from 2014 to 2026
Figure Japan Obesity Therapeutic Drugs Market Size and Growth Rate of Application 3 from 2014 to 2026
-
Table Japan Obesity Therapeutic Drugs Production by Regions
-
Table Japan Obesity Therapeutic Drugs Production Share by Regions
-
Figure Japan Obesity Therapeutic Drugs Production Share by Regions in 2014
-
Figure Japan Obesity Therapeutic Drugs Production Share by Regions in 2018
-
Figure Japan Obesity Therapeutic Drugs Production Share by Regions in 2026
-
Table Japan Obesity Therapeutic Drugs Consumption by Regions
-
Table Japan Obesity Therapeutic Drugs Consumption Share by Regions
-
Figure Japan Obesity Therapeutic Drugs Consumption Share by Regions in 2014
-
Figure Japan Obesity Therapeutic Drugs Consumption Share by Regions in 2018
-
Figure Japan Obesity Therapeutic Drugs Consumption Share by Regions in 2026
-
Table Hokkaido Obesity Therapeutic Drugs Consumption by Types from 2014 to 2026
-
Table Hokkaido Obesity Therapeutic Drugs Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Obesity Therapeutic Drugs Consumption Share by Types in 2014
-
Figure Hokkaido Obesity Therapeutic Drugs Consumption Share by Types in 2018
-
Figure Hokkaido Obesity Therapeutic Drugs Consumption Share by Types in 2026
-
Table Hokkaido Obesity Therapeutic Drugs Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Obesity Therapeutic Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Obesity Therapeutic Drugs Consumption Share by End-Users in 2014
-
Figure Hokkaido Obesity Therapeutic Drugs Consumption Share by End-Users in 2018
-
Figure Hokkaido Obesity Therapeutic Drugs Consumption Share by End-Users in 2026
-
Table Tohoku Obesity Therapeutic Drugs Consumption by Types from 2014 to 2026
-
Table Tohoku Obesity Therapeutic Drugs Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Obesity Therapeutic Drugs Consumption Share by Types in 2014
-
Figure Tohoku Obesity Therapeutic Drugs Consumption Share by Types in 2018
-
Figure Tohoku Obesity Therapeutic Drugs Consumption Share by Types in 2026
-
Table Tohoku Obesity Therapeutic Drugs Consumption by End-Users from 2014 to 2026
-
Table Tohoku Obesity Therapeutic Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Obesity Therapeutic Drugs Consumption Share by End-Users in 2014
-
Figure Tohoku Obesity Therapeutic Drugs Consumption Share by End-Users in 2018
-
Figure Tohoku Obesity Therapeutic Drugs Consumption Share by End-Users in 2026
-
Table Kanto Obesity Therapeutic Drugs Consumption by Types from 2014 to 2026
-
Table Kanto Obesity Therapeutic Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kanto Obesity Therapeutic Drugs Consumption Share by Types in 2014
-
Figure Kanto Obesity Therapeutic Drugs Consumption Share by Types in 2018
-
Figure Kanto Obesity Therapeutic Drugs Consumption Share by Types in 2026
-
Table Kanto Obesity Therapeutic Drugs Consumption by End-Users from 2014 to 2026
-
Table Kanto Obesity Therapeutic Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Obesity Therapeutic Drugs Consumption Share by End-Users in 2014
-
Figure Kanto Obesity Therapeutic Drugs Consumption Share by End-Users in 2018
-
Figure Kanto Obesity Therapeutic Drugs Consumption Share by End-Users in 2026
-
Table Chubu Obesity Therapeutic Drugs Consumption by Types from 2014 to 2026
-
Table Chubu Obesity Therapeutic Drugs Consumption Share by Types from 2014 to 2026
-
Figure Chubu Obesity Therapeutic Drugs Consumption Share by Types in 2014
-
Figure Chubu Obesity Therapeutic Drugs Consumption Share by Types in 2018
-
Figure Chubu Obesity Therapeutic Drugs Consumption Share by Types in 2026
-
Table Chubu Obesity Therapeutic Drugs Consumption by End-Users from 2014 to 2026
-
Table Chubu Obesity Therapeutic Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Obesity Therapeutic Drugs Consumption Share by End-Users in 2014
-
Figure Chubu Obesity Therapeutic Drugs Consumption Share by End-Users in 2018
-
Figure Chubu Obesity Therapeutic Drugs Consumption Share by End-Users in 2026
-
Table Kinki Obesity Therapeutic Drugs Consumption by Types from 2014 to 2026
-
Table Kinki Obesity Therapeutic Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kinki Obesity Therapeutic Drugs Consumption Share by Types in 2014
-
Figure Kinki Obesity Therapeutic Drugs Consumption Share by Types in 2018
-
Figure Kinki Obesity Therapeutic Drugs Consumption Share by Types in 2026
-
Table Kinki Obesity Therapeutic Drugs Consumption by End-Users from 2014 to 2026
-
Table Kinki Obesity Therapeutic Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Obesity Therapeutic Drugs Consumption Share by End-Users in 2014
-
Figure Kinki Obesity Therapeutic Drugs Consumption Share by End-Users in 2018
-
Figure Kinki Obesity Therapeutic Drugs Consumption Share by End-Users in 2026
-
Table Chugoku Obesity Therapeutic Drugs Consumption by Types from 2014 to 2026
-
Table Chugoku Obesity Therapeutic Drugs Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Obesity Therapeutic Drugs Consumption Share by Types in 2014
-
Figure Chugoku Obesity Therapeutic Drugs Consumption Share by Types in 2018
-
Figure Chugoku Obesity Therapeutic Drugs Consumption Share by Types in 2026
-
Table Chugoku Obesity Therapeutic Drugs Consumption by End-Users from 2014 to 2026
-
Table Chugoku Obesity Therapeutic Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Obesity Therapeutic Drugs Consumption Share by End-Users in 2014
-
Figure Chugoku Obesity Therapeutic Drugs Consumption Share by End-Users in 2018
-
Figure Chugoku Obesity Therapeutic Drugs Consumption Share by End-Users in 2026
-
Table Shikoku Obesity Therapeutic Drugs Consumption by Types from 2014 to 2026
-
Table Shikoku Obesity Therapeutic Drugs Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Obesity Therapeutic Drugs Consumption Share by Types in 2014
-
Figure Shikoku Obesity Therapeutic Drugs Consumption Share by Types in 2018
-
Figure Shikoku Obesity Therapeutic Drugs Consumption Share by Types in 2026
-
Table Shikoku Obesity Therapeutic Drugs Consumption by End-Users from 2014 to 2026
-
Table Shikoku Obesity Therapeutic Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Obesity Therapeutic Drugs Consumption Share by End-Users in 2014
-
Figure Shikoku Obesity Therapeutic Drugs Consumption Share by End-Users in 2018
-
Figure Shikoku Obesity Therapeutic Drugs Consumption Share by End-Users in 2026
-
Table Kyushu Obesity Therapeutic Drugs Consumption by Types from 2014 to 2026
-
Table Kyushu Obesity Therapeutic Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Obesity Therapeutic Drugs Consumption Share by Types in 2014
-
Figure Kyushu Obesity Therapeutic Drugs Consumption Share by Types in 2018
-
Figure Kyushu Obesity Therapeutic Drugs Consumption Share by Types in 2026
-
Table Kyushu Obesity Therapeutic Drugs Consumption by End-Users from 2014 to 2026
-
Table Kyushu Obesity Therapeutic Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Obesity Therapeutic Drugs Consumption Share by End-Users in 2014
-
Figure Kyushu Obesity Therapeutic Drugs Consumption Share by End-Users in 2018
-
Figure Kyushu Obesity Therapeutic Drugs Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Arena Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arena Pharmaceuticals
Figure Sales and Growth Rate Analysis of Arena Pharmaceuticals
Figure Revenue and Market Share Analysis of Arena Pharmaceuticals
Table Product and Service Introduction of Arena Pharmaceuticals
Table Company Profile and Development Status of Takeda Pharmaceutical
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical
Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical
Figure Revenue and Market Share Analysis of Takeda Pharmaceutical
Table Product and Service Introduction of Takeda Pharmaceutical
Table Company Profile and Development Status of Orexigen Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Orexigen Therapeutics
Figure Sales and Growth Rate Analysis of Orexigen Therapeutics
Figure Revenue and Market Share Analysis of Orexigen Therapeutics
Table Product and Service Introduction of Orexigen Therapeutics
Table Company Profile and Development Status of Sanofi
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
Figure Sales and Growth Rate Analysis of Sanofi
Figure Revenue and Market Share Analysis of Sanofi
Table Product and Service Introduction of Sanofi
Table Company Profile and Development Status of GlaxoSmithKline
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
Figure Revenue and Market Share Analysis of GlaxoSmithKline
Table Product and Service Introduction of GlaxoSmithKline
Table Company Profile and Development Status of Eisai
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai
Figure Sales and Growth Rate Analysis of Eisai
Figure Revenue and Market Share Analysis of Eisai
Table Product and Service Introduction of Eisai
Table Company Profile and Development Status of Vivus
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vivus
Figure Sales and Growth Rate Analysis of Vivus
Figure Revenue and Market Share Analysis of Vivus
Table Product and Service Introduction of Vivus
Table Company Profile and Development Status of Shionogi
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shionogi
Figure Sales and Growth Rate Analysis of Shionogi
Figure Revenue and Market Share Analysis of Shionogi
Table Product and Service Introduction of Shionogi
Table Company Profile and Development Status of Norgine
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Norgine
Figure Sales and Growth Rate Analysis of Norgine
Figure Revenue and Market Share Analysis of Norgine
Table Product and Service Introduction of Norgine
Table Company Profile and Development Status of Novo Nordisk
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk
Figure Sales and Growth Rate Analysis of Novo Nordisk
Figure Revenue and Market Share Analysis of Novo Nordisk
Table Product and Service Introduction of Novo Nordisk
Table Company Profile and Development Status of Roche
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
Figure Sales and Growth Rate Analysis of Roche
Figure Revenue and Market Share Analysis of Roche
Table Product and Service Introduction of Roche
-
